HCPCS Codes Similar to S0080

HCPCS Codes Similar to “S0080” Code.
Injection, pentamidine isethionate, 300 mg

J2516 Injection, pentamidine isethionate, 1 mg Code added date: 20260101 Code effective date: 20260101 TXT \| PDF \| XML \| JSON	J2545 Pentamidine isethionate, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per 300 mg Code added date: 19920101 Code effective date: 20080101 TXT \| PDF \| XML \| JSON
J7676 Pentamidine isethionate, inhalation solution, compounded product, administered through dme, unit dose form, per 300 mg Code added date: 20080101 Code effective date: 20080101 TXT \| PDF \| XML \| JSON	C9448 Netupitant 300 mg and palonosetron 0.5 mg, oral Code added date: 20150401 Code effective date: 20150701 TXT \| PDF \| XML \| JSON
J0736 Injection, clindamycin phosphate, 300 mg Code added date: 20230701 Code effective date: 20240101 TXT \| PDF \| XML \| JSON	J0737 Injection, clindamycin phosphate (baxter), not therapeutically equivalent to j0736, 300 mg Code added date: 20230701 Code effective date: 20240101 TXT \| PDF \| XML \| JSON
J0752 Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) Code added date: 20251001 Code effective date: 20251001 TXT \| PDF \| XML \| JSON	J1436 Injection, etidronate disodium, per 300 mg Code added date: 19900101 Code effective date: 19970101 TXT \| PDF \| XML \| JSON
J1730 Injection, diazoxide, up to 300 mg Code added date: 19820101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	J2010 Injection, lincomycin hcl, up to 300 mg Code added date: 19820101 Code effective date: 19970101 TXT \| PDF \| XML \| JSON
J8655 Netupitant 300 mg and palonosetron 0.5 mg, oral Code added date: 20160101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	Q0220 Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromised immune systems or for whom vaccination with any available covid-19 vaccine is not recommended due to a history of severe adverse reaction to a covid-19 vaccine(s) and/or covid-19 vaccine component(s), 300 mg Code added date: 20211208 Code effective date: 20241213 TXT \| PDF \| XML \| JSON
Q9962 High osmolar contrast material, 300-349 mg/ml iodine concentration, per ml Code added date: 20050701 Code effective date: 20050701 TXT \| PDF \| XML \| JSON	Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Code added date: 20080101 Code effective date: 20080101 TXT \| PDF \| XML \| JSON